Agents Used in Antiretroviral Therapy
Summary
- Elvitegravir is currently available in the United States as part of 2 coformulated single-tablet regimens cobicistat/elvitegravir/emtricitabine/tenofovir DF and cobicistat/elvitegravir/emtricitabine/tenofovir AF
- Cobicistat/elvitegravir/emtricitabine/tenofovir DF is indicated as a complete regimen for treatment of HIV infection in ART-naive adults with an estimated creatinine clearance ≥ 70 mL/min[FDA COBI/EVG/FTC/TDF]
- Cobicistat/elvitegravir/emtricitabine/tenofovir AF is indicated as a complete regimen for treatment of HIV infection in ART-naive adults and adolescents with an estimated creatinine clearance ≥ 30 mL/min and as a switch regimen in patients who are virologically suppressed on their current regimen[FDA COBI/EVG/FTC/TAF]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content